Nouveau Nonprofits: The Broad Institute’s Big Money, Business & Public Benefit Mix – The Nonprofit Quarterly (registration)
The Nonprofit Quarterly (registration) |
Nouveau Nonprofits: The Broad Institute’s Big Money, Business & Public Benefit Mix
The Nonprofit Quarterly (registration) Zhang and colleagues then patented an application of a related genome-editing technique called CRISPR–Cpf1 and, through the Broad and other institutions, granted Editas an exclusive license to use this technology for medical applications.”. |
The Nonprofit Quarterly (registration) |
Nouveau Nonprofits: The Broad Institute’s Big Money, Business & Public Benefit Mix
The Nonprofit Quarterly (registration) Zhang and colleagues then patented an application of a related genome-editing technique called CRISPR–Cpf1 and, through the Broad and other institutions, granted Editas an exclusive license to use this technology for medical applications.”. |
Immuno-Oncology News |
PD-1 Expression in Immune T-cells Can Help Define Immunotherapy Strategies for Lung Cancer Patients
Immuno-Oncology News A team of researchers from Emory University’s Winship Cancer Institute in Atlanta evaluated blood samples from 29 patients with advanced non-small cell lung cancer (NSCLC) undergoing immunotherapy treatment with PD-1 or PD-L1 inhibitors. |
Genetic Engineering & Biotechnology News |
CRISPR-SMART Cells Regenerate Cartilage, Secrete Anti-Arthritis Drug
Genetic Engineering & Biotechnology News We have anti-arthritis drugs. What we lack is the ability to deploy them when and where they are needed in the body. The drugs would be far more effective, and occasion fewer side effects, if they were to appear only in response to inflammation, and … Fighting arthritis may be easier thanks to SMART cells built on CRISPR gene-editing toolFirstpost New Arthritis Vaccine Shows Promise In Fighting Inflammation [VIDEO]University Herald |
|
Cancer and Stem Cell Growth Encouraged by the Same Gene
Genetic Engineering & Biotechnology News A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.The finding adds … |
|
Cancer and Stem Cell Growth Encouraged by the Same Gene
Genetic Engineering & Biotechnology News A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.The finding adds … |
|
Algorithm may be ‘transformative’ for predicting GVHD after stem cell transplant
Healio Researchers at Mount Sinai Health System developed a two-biomarker model that can predict graft-versus-host disease before signs and symptoms appear in individuals who underwent allogeneic hematopoietic stem cell transplant, according to study results … |
Medical Xpress |
Single gene encourages growth of intestinal stem cells, supporting ‘niche’ cells—and cancer
Medical Xpress A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers. The finding … |